Patents matching “treatment”

US 8629127

Compositions and methods of treatment for inflammatory diseases

The Regents of the University of Oklahoma · Granted Jan 14, 2014 · Expires Jan 9, 2034

US 8623330

Emollient foams for treatment of seborrheic dermatitis

Precision Dermatology, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

US 8623847

Compositions for treatment of inflammatory diseases

The Regents of the University of Oklahoma · Granted Jan 7, 2014 · Expires Jan 2, 2034

US 8618080

Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

OM PHARMA · Granted Dec 31, 2013 · Expires Dec 26, 2033

US 8618058

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

Soricimed Biopharma Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

US 8616429

Structure containing wound treatment material

Covidien LP · Granted Dec 31, 2013 · Expires Dec 26, 2033

US 8614179

Antibacterial combination therapy for the treatment of gram positive bacterial infections

E-Therapeutics PLC · Granted Dec 24, 2013 · Expires Dec 19, 2033

US 8609088

Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

US 8609728

Treatment for pulmonary hypertension

United Therapeutics Corporation · Granted Dec 17, 2013 · Expires Dec 12, 2033

US 8604011

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Dec 10, 2013 · Expires Dec 5, 2033

US 8603462

Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

The United States of America—Department of Veterans Affairs · Granted Dec 10, 2013 · Expires Dec 5, 2033

US 8598203

Treatment of Crohn's disease with laquinimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 3, 2013 · Expires Nov 28, 2033

US 8592456

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

4SC DISCOVERY GMBH · Granted Nov 26, 2013 · Expires Nov 21, 2033

US 8591922

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

Jazz Pharmaceuticals, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

US 8591890

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

University of Connecticut Health Center · Granted Nov 26, 2013 · Expires Nov 21, 2033

US 8586044

Treatment of chronic pelvic pain syndrome

Northwestern University · Granted Nov 19, 2013 · Expires Nov 14, 2033

US 8580748

Peptides for the treatment of hearing

Compass Therapeutics LLC · Granted Nov 12, 2013 · Expires Nov 7, 2033

US 8580735

Local complement inhibition for treatment of complement-mediated disorders

Apellis Pharmaceuticals, Inc. · Granted Nov 12, 2013 · Expires Nov 7, 2033

US 8580738

Methods for treatment of reperfusion injury and other cardiac conditions

The Board of Regents of the University of Texas System · Granted Nov 12, 2013 · Expires Nov 7, 2033

US 8580249

Cell therapy for the treatment of lysosomal storage disorders

Regents of the University of Minnesota · Granted Nov 12, 2013 · Expires Nov 7, 2033

AU 2012249536

Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

CELGENE CORP [CH] · Granted Nov 7, 2013 · Expires Nov 2, 2033

US 8575312

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

US 8569320

Topical composition for the treatment of actinic keratosis

Almirall Hermal GmbH · Granted Oct 29, 2013 · Expires Oct 24, 2033

US 8569379

Use of rasagiline for the treatment of olfactory dysfunction

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 29, 2013 · Expires Oct 24, 2033